MATTHIAS
DROSTEN
Investigador
Memorial Sloan Kettering Cancer Center
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Memorial Sloan Kettering Cancer Center (2)
2018
-
Allele-specific mechanisms of activation of mek1 mutants determine their properties
Cancer Discovery, Vol. 8, Núm. 5, pp. 648-661
2017
-
Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS
Nature, Vol. 548, Núm. 7666, pp. 234-238